Additional Relevant Details BIND Therapeutics has received two bids that are qualified to participate in the Court authorized auction beginning at 10 a.m. EST on July 25, 2016. The bids are in addition to Pfizer Inc.'s initial stalking horse bid of approximately $20 million under Section 363 of theU.S. Bankruptcy Code.The U.S. Bankruptcy Court has authorized BIND to proceed with an auction on July 25, 2016 and the Company intends to select the highest and best offer at the conclusion of the auction. The winning bid is subject to U.S. Bankruptcy Court approval and a hearing is scheduled to take place on July 27, 2016.BIND initiated voluntary Chapter 11 bankruptcy protection on May 1, 2016 and is conducting a sale of assets pursuant to Section 363 of the Bankruptcy Code.